Marais, AD
25  Ergebnisse:
Personensuche X
?
1

Identification and properties of the proline664-leucine mut..:

Rubinsztein, DC ; Coetzee, GA ; Marais, AD...
Journal of Lipid Research.  33 (1992)  11 - p. 1647-1655 , 1992
 
?
2

Treatment of hypercholesterolemia with the HMG CoA reductas..:

Berger, GMB ; Marais, AD ; Seftel, HC...
Cardiovascular Drugs and Therapy.  3 (1989)  2 - p. 219-227 , 1989
 
?
3

Step‐by‐step diagnosis and management of the nocebo/drucebo..:

Penson, PE ; Bruckert, E ; Marais, D...
https://researchonline.ljmu.ac.uk/id/eprint/16546/1/J%20cachexia%20sarcopenia%20muscle%20-%202022%20-%20Penson%20-%20Step%E2%80%90by%E2%80%90step%20diagnosis%20and%20management%20of%20the%20nocebo%20drucebo%20effect%20in.pdf.  , 2022
 
?
4

Familial hypercholesterolaemia and its management in South ..:

Marais, AD
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802364/.  , 2019
 
?
5

Familial hypercholesterolaemia workshop for leveraging poin..:

Marais, AD ; Kotze, MJ ; Khine, AA...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802372/.  , 2019
 
?
6

Severe hypercholesterolaemia with a high risk of atheroscle..:

Marais, AD ; Segal, D
https://www.ajol.info/index.php/samj/article/view/178628/168005.  , 2018
 
?
7

South African dyslipidaemia guideline consensus statement:

Klug, EQ ; Raal, FJ ; Marais, AD...
http://www.journals.ac.za/index.php/SAHJ/article/view/1855/951.  , 2017
 
?
8

Pooling and expanding registries of familial hypercholester..:

EAS Familial Hypercholesterolaemia Studies Collaboration ; Vallejo-Vaz, AJ ; Akram, A...
https://openaccess.sgul.ac.uk/id/eprint/108641/1/1-s2.0-S1567568816300496-main.pdf.  , 2016
 
?
9

The lipid-lowering effects of lomitapide are unaffected by ..:

Stefanutti, C ; Blom, DJ ; Averna, MR...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573555/.  , 2015
 
?
 
?
13

Identification and properties of the proline664-leucine mut..:

DC Rubinsztein ; GA Coetzee ; AD Marais...
http://www.sciencedirect.com/science/article/pii/S0022227520413872.  , 1992
 
?
14

Impact of nutraceuticals on markers of systemic inflammatio..:

M Ruscica (11508901) ; PE Penson (11508904) ; N Ferri (11508907)...
https://figshare.com/articles/journal_contribution/Impact_of_nutraceuticals_on_markers_of_systemic_inflammation_Potential_relevance_to_cardiovascular_diseases_A_position_paper_from_the_International_Lipid_Expert_Panel_ILEP_/16713892.  , 2021
 
?
15

Clinical standards for the diagnosis, treatment and prevent..:

Migliori, GB ; Wu, SJ ; Matteelli, A...
https://discovery.ucl.ac.uk/id/eprint/10144483/1/Hamada_Clinical%20standards%20for%20the%20diagnosis,%20treatment%20and%20prevention%20of%20TB%20infection_VoR.pdf.  , 2022
 
1-15